Stakeholder engagement is a fundamental component in the development of policy. Various structures, including public consultation, have been developed to ensure that the voice of the public and the patient is represented in the policy development process.
Currently, there is no formal consultation structure that applies uniquely to whole genome sequencing. However, the whole issue of genetics, genome sequencing, service provision and research, in the context of future policy developments in relation to precision/personalised medicine is currently under review by the Department.